When traditional treatments were no longer effective in relieving his depression, Mathias tried psilocybin therapy outside the current regulatory framework in Belgium. It saved him.
Join us for an inspiring gathering at the intersection of science, culture, and consciousness. This special event, in partnership with PsychedeliCare.eu, will celebrate the upcoming
On World Mental Health Day and as part of the signature collection for the EU Citizens Initiative called Psychedelicare.eu,The acclaimed movie Crazywise will be screened by
📢 PsychedeliCare will be present at the Piante Maestre Festival in Milan, October 4–5! 🌱✨ At our stand, we’ll be offering 1:1 consultations for those
📍 Friday, October 24, 2025, from 9am to 1.30pm – Aula Magna, Faculty of Pharmacy and Food Sciences, Campus Diagonal, University of Barcelona This conference
Max Libert (name changed) is an autistic young man living in Bavaria. Germany recently approved a compassionate use programme under which patients suffering from treatment resistant depression may undergo Psychedelic Assisted Therapy using Psilocybin. And yet, Max is facing years behind bars for self-medicating with mushrooms containing this very compound.
Alexis Arragon (French Team Lead) was invited to present a lecture at the 2025 Congress of Fédération Addiction that took places on the 22-23 of
PsychedeliCare present at the lecture organised by the Amsterdam Psychedelic Research Association on the 10th of April, 2025 On April 10th 2025, APRA will host
On March 20th, Psychedelic Society Maastricht will host the Museum of Consciousness at Maastricht University in The Netherlands. Created and facilitated by esteemed researcher and innovator Carl Hayden Smith, the
On March 4th, the French PsychedeliCare team hosted its launch event, bringing together psychiatrists, journalists, authors, and researchers for an evening to discuss the role of psychedelics
